PH19228A - N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof - Google Patents

N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof

Info

Publication number
PH19228A
PH19228A PH27729A PH27729A PH19228A PH 19228 A PH19228 A PH 19228A PH 27729 A PH27729 A PH 27729A PH 27729 A PH27729 A PH 27729A PH 19228 A PH19228 A PH 19228A
Authority
PH
Philippines
Prior art keywords
methyl
ethenediamine
methylenedioxybenzyl
furanyl
thio
Prior art date
Application number
PH27729A
Other languages
English (en)
Inventor
Leonardo De Vincentiis
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH19228(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Publication of PH19228A publication Critical patent/PH19228A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH27729A 1981-08-18 1982-08-13 N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof PH19228A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Publications (1)

Publication Number Publication Date
PH19228A true PH19228A (en) 1986-02-12

Family

ID=11208027

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27729A PH19228A (en) 1981-08-18 1982-08-13 N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof

Country Status (23)

Country Link
US (1) US4431664A (sv)
JP (1) JPS5859982A (sv)
KR (1) KR860000851B1 (sv)
AR (1) AR230444A1 (sv)
AT (1) AT383597B (sv)
AU (1) AU533719B2 (sv)
BE (1) BE894093A (sv)
CA (1) CA1182121A (sv)
CH (1) CH650259A5 (sv)
DE (1) DE3230265C2 (sv)
DK (1) DK156067C (sv)
ES (1) ES8306372A1 (sv)
FR (1) FR2511675A1 (sv)
GB (1) GB2104071B (sv)
GR (1) GR76260B (sv)
IT (1) IT1168163B (sv)
LU (1) LU84340A1 (sv)
NL (1) NL186447C (sv)
NO (1) NO159448C (sv)
PH (1) PH19228A (sv)
PT (1) PT75440B (sv)
SE (1) SE448456B (sv)
ZA (1) ZA825718B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1175808B (it) * 1984-03-07 1987-07-15 Ausonia Farma Srl Procedimento per la preparazione di composto con attivita' antiulcera
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
JPS63502903A (ja) * 1986-03-28 1988-10-27 ジヤヌス・フアルマチエウテイシ・エスアールエル 治療学的抗潰瘍活性を有する化合物の合成方法
HU9203905D0 (en) * 1989-04-05 1993-04-28 Glaxo Group Ltd Method for producing ranitidine
JPH0416036U (sv) * 1990-05-31 1992-02-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140681A (en) * 1974-11-08 1979-02-20 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK156067C (da) 1989-12-04
SE8204670L (sv) 1983-02-19
PT75440A (en) 1982-09-01
SE448456B (sv) 1987-02-23
AU8673182A (en) 1983-02-24
DK156067B (da) 1989-06-19
ZA825718B (en) 1983-06-29
FR2511675B1 (sv) 1984-02-10
DK357182A (da) 1983-02-19
NO159448C (no) 1988-12-28
NL8203160A (nl) 1983-03-16
IT1168163B (it) 1987-05-20
AU533719B2 (en) 1983-12-08
GR76260B (sv) 1984-08-04
IT8123546A0 (it) 1981-08-18
KR840001162A (ko) 1984-03-28
KR860000851B1 (ko) 1986-07-09
DE3230265A1 (de) 1983-03-03
ATA312282A (de) 1986-12-15
AT383597B (de) 1987-07-27
CH650259A5 (it) 1985-07-15
US4431664A (en) 1984-02-14
ES515068A0 (es) 1983-06-01
BE894093A (nl) 1982-12-01
NO822801L (no) 1983-02-21
GB2104071A (en) 1983-03-02
AR230444A1 (es) 1984-04-30
PT75440B (en) 1986-02-04
DE3230265C2 (de) 1984-09-20
GB2104071B (en) 1985-03-27
SE8204670D0 (sv) 1982-08-12
JPS6335631B2 (sv) 1988-07-15
CA1182121A (en) 1985-02-05
NL186447B (nl) 1990-07-02
LU84340A1 (fr) 1983-02-28
JPS5859982A (ja) 1983-04-09
FR2511675A1 (fr) 1983-02-25
NO159448B (no) 1988-09-19
NL186447C (nl) 1990-12-03
ES8306372A1 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
IT8124866A0 (it) Derivato tiazolico, procedimento per la sua preparazione e relative composizioni farmaceutiche.
HUT47102A (en) Process for producing 2-(azoylmethyl)-2-aryl-1,3-dioxolanes, their salts and pharmaceutical compositions comprising such compounds
IL62039A (en) 2-(2-(1,4-benzodioxanyl))-2-imidazoline and non-toxic salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
IL66227A (en) N-(2-(5-dimethylaminomethyl-furan-2-yl-methylthio)-ethyl)-benzamide derivatives and their salts,their preparation and pharmaceutical compositions containing them
PH19228A (en) N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
ZA837332B (en) Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form
IL70401A (en) N(2-((5-(tricycloalkylamino-methyl)-2-furanyl)-methyl-thio)-ethyl) n'-2-nitro-1,1-ethenediamine derivatives,their preparation and pharmaceutical compositions containing them
NZ191699A (en) N-(1-methyl-2-pyrrolidinyl methyl)-2,3-dimethoxy-5-methyl-sulphamoyl benzamide derivatives pharmaceutical compositions
IT8121960A0 (it) Composti ad attivita' gaba simile, procedimento per prepararli e composizioni farmaceutiche cheli comprendono.
MA19602A1 (fr) Composes d'amino-oxazolyle, procede pour leur preparation, preparations pharmaceutiques qui contiennent ces composes, et leur application
DE3264595D1 (en) N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
YU260882A (en) Process for preparing n-(2-(*(5-(dimethyl-amino)-methyl-2-furanyl)-methyl*-thio)-ethyl*-n'-methyl-2-nitro-1,1-ethene diamine
IT1167794B (it) Procedimento per la preparazione del n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1 etendiamina
IL65512A (en) 3-(2-(3-alkyl and alkenyl-4-piperidyl)-ethyl)-indoles,their preparation and pharmaceutical compositions containing them
IT1147325B (it) Composto ad attivita' psicostimolante e antidepressiva,processo per la sua preparazione e composizioni farmaceutiche relative
ES497737A0 (es) Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina
DK157494C (da) Fremgangsmaade til fremstilling af n-(2(((5-((dimethylamino)-methyl)-2-furanyl)methyl)thio)ethyl)-n'(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin
IL70752A0 (en) (+-)2-(3,4-methylenedioxyphenethyl)-5-(3-carbamoyl-alpha,4-dihydroxybenzyl)pyrrolidines and salts thereof,their preparation and pharmaceutical compositions containing them
IT1149947B (it) Procedimento di preparazione della n-(2-(((5-(dimetilamino)-metil-2-flranil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etilendiamina
ES543966A0 (es) Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)-metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etendiamina
IT8221203A0 (it) Composizione farmaceutica acarattere di collirio, eprocedimento per la sua preparazione.
IT1167489B (it) Procedimento per la preparazione della n-(2-(((5-(dimetilamino)-metil-2-furil)-metil)-tio)-)n'-metil-2-nitro-1,1-etilendiamina
IT1151102B (it) Composto ad attivita' analgesica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1095386B (it) 2-(2-tenciltio)-propionilglicina,metodo per la sua preparazione e composizioni farmaceutiche che la contengono